Header Logo

Connection

Ravindre Panchia to Risk Assessment

Back to Details
This is a "connection" page, showing publications Ravindre Panchia has written about Risk Assessment.
Ravindre Panchia
Connection Strength
0,036
Risk Assessment
  1. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018 11; 15(11):e1002690.
    View in: PubMed
    Score: 0,036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.